BIOMARKER:

ATR mutation

Entrez ID:

ATR mutation ATR mutation	Solid Tumor Solid Tumor	ATR mutation ATR mutation	Solid Tumor Solid Tumor	Immunotherapy Sensitive: B - Late Trials	Immunotherapy Sensitive: B - Late Trials
ATR mutation ATR mutation	Gastroesophageal Junction Adenocarcinoma Gastroesophageal Junction Adenocarcinoma	ATR mutation ATR mutation	Gastroesophageal Junction Adenocarcinoma Gastroesophageal Junction Adenocarcinoma	Immunotherapy Sensitive: C3 – Early Trials	Immunotherapy Sensitive: C3 – Early Trials
ATR mutation ATR mutation	Gastric Adenocarcinoma Gastric Adenocarcinoma	ATR mutation ATR mutation	Gastric Adenocarcinoma Gastric Adenocarcinoma	Immunotherapy Sensitive: C3 – Early Trials	Immunotherapy Sensitive: C3 – Early Trials
ATR mutation ATR mutation	Colon Cancer Colon Cancer	ATR mutation ATR mutation	Colon Cancer Colon Cancer	Immunotherapy Sensitive: C3 – Early Trials	Immunotherapy Sensitive: C3 – Early Trials
ATR mutation ATR mutation	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	ATR mutation ATR mutation	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	talazoparib Sensitive: C3 – Early Trials	talazoparib Sensitive: C3 – Early Trials
ATR mutation ATR mutation	Colorectal Cancer CRC	ATR mutation ATR mutation	Colorectal Cancer CRC	M6620 + SNB-101 Sensitive: D – Preclinical	M6620 + SNB-101 Sensitive: D – Preclinical
ATR mutation ATR mutation	Colorectal Cancer CRC	ATR mutation ATR mutation	Colorectal Cancer CRC	M6620 Sensitive: D – Preclinical	M6620 Sensitive: D – Preclinical
ATR mutation ATR mutation	Colorectal Cancer CRC	ATR mutation ATR mutation	Colorectal Cancer CRC	SNB-101 Sensitive: D – Preclinical	SNB-101 Sensitive: D – Preclinical